<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04540458</url>
  </required_header>
  <id_info>
    <org_study_id>1052761</org_study_id>
    <nct_id>NCT04540458</nct_id>
  </id_info>
  <brief_title>3D Maternal Fetal Bonding</brief_title>
  <official_title>Effect of 3D Ultrasounds and 3D Printed Models on Maternal and Paternal Fetal Attachment and Anxiety and Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether 3D models of fetus' face created from 3D ultrasound will increase&#xD;
      maternal and paternal attachment, lower stress, anxiety and depression and have improved&#xD;
      life-style choices during pregnancy. Half of participants will receive 3D model and half will&#xD;
      receive a picture of 3D ultrasound of their baby.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>3D ultrasound and picture of ultrasound or 3D ultrasound and printed model of fetal face</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal Antenatal Attachment Scale (MAAS)</measure>
    <time_frame>5 minutes</time_frame>
    <description>The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Paternal Antenatal Attachment Scale (PAAS)</measure>
    <time_frame>5 minutes</time_frame>
    <description>The PAAS is a 16 item questionnaire measuring paternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal anxiety</measure>
    <time_frame>3 minutes</time_frame>
    <description>7-question Generalized Anxiety Disorder questionnaire (GAD-7) will be administered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Paternal depression</measure>
    <time_frame>3 minutes</time_frame>
    <description>9-question Patient Health Questionnaire (PHQ-9) will be administered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal depression</measure>
    <time_frame>3 minutes</time_frame>
    <description>9-question Patient Health Questionnaire (PHQ-9) will be administered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Paternal anxiety</measure>
    <time_frame>3 minutes</time_frame>
    <description>7-question Generalized Anxiety Disorder questionnaire (GAD-7) will be administered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal stress</measure>
    <time_frame>3 minutes</time_frame>
    <description>11-question Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ-R2) will be administered.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Maternal-Fetal Relations</condition>
  <condition>Paternal Behavior</condition>
  <condition>Maternal Behavior</condition>
  <arm_group>
    <arm_group_label>3D printed model</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Mother or Mother/Father is given 3D printed model of fetus' face</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Mother or Mother/Father is given printed picture of 3D ultrasound of fetus</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3D printed model</intervention_name>
    <description>Mother or Mother/Father is given 3D printed model of fetus' face</description>
    <arm_group_label>3D printed model</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mother or Mother/Father is given a picture of 3D ultrasound of fetus</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age - Female 19-45 years of age; Male &gt; 19 years of age&#xD;
&#xD;
          -  Currently pregnant (&lt; 32 weeks gestation)&#xD;
&#xD;
          -  Have normal 20-week ultrasound&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having received more than 3 ultrasounds prior to study&#xD;
&#xD;
          -  Medical need for additional ultrasounds&#xD;
&#xD;
          -  Multiple fetuses&#xD;
&#xD;
          -  &gt; 31 weeks gestation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Cote, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Creighton University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Cote, MD</last_name>
    <phone>402-343-8511</phone>
    <email>john.cote@alegent.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Nubel</last_name>
    <phone>402-280-4032</phone>
    <email>carolinenubel@creighton.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Creighton University</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68178</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Santek</last_name>
      <phone>402-280-2322</phone>
      <email>nicolesantek@creighton.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Badura Brack, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

